Pharma R&D Summit - June 6-7, 2005 - Sarasota, FL - Lyophilization Conferences 2005

Pharma R&D Summit
June 6-7, 2005 - Sarasota, FL
Ritz Carlton Sarasota, FL
The pharmaceutical industry continues to face an ever-changing, increasingly complex business environment, making it imperative for drug discovery and development efforts to incorporate new technologies in order to reduce time to market and survive in today?s complex marketplace. Escalating R&D costs, generic competition and public pressure for new drugs at reduced costs are making the timely recovery of high drug development costs more difficult for pharmaceutical companies. In the post-genomic era, there are new and exciting methods to be examined and utilized by the life science market that will expedite the drug discovery process.
The Pharma R&D Summit is an executive gathering that will bring together senior-level pharmaceutical executives with a select and diversified group of leading-edge Solution Providers to converge over these vital industry issues. Within a focused and professional environment, the Pharma R&D Summit will seamlessly integrate one-on-one meetings and informal networking and leisure activities.
Key Topics for the Pharma R&D 2005 Summit Program Include:
Enhancing R&D Productivity through Re-Engineering the Draft Discovery Paradigm
Ongoing Development in the Realm of Biomarkers
Pre-clinical Studies: What is the Impact of New Technologies on Improving Target Validation and Reducing Cycle Time
Advantages and Challenges in Utilizing RNAi to Identify and Validate Novel Drug Target
Assay Development: Cell Based Assays Versus In-Vitro Assays
Challenges in Handling Concept Innovation for Small Versus Big Pharma
Increasing the Output of Animal Models
Methods in Transitioning Drugs in the Pipeline: the Jump from In vitro to Human Testing
Pharmacogenomics in Clinical Trial-Practical, Ethical and Regulatory issues and Clinical Validation
Cutting Edge Technologies to Expedite Drug Discovery
Beyond Toxicogenomics: New Advances in Toxicogenomics
Outsourcing (Capacity and or Expertise) and Partnerships in R&D
Filling Critical Pipeline Gaps: Alliances, Co-development and Partnering
Impact of Globalization on the Pharmaceutical Industry
Knowledge Management in Research and Development: Making Better and Faster Decisions through the drug development phase
Computational Tool: Make the Most from your Data